Description

Levofloxacin-Novofarm Solution for Infusions 5 mg/ml. 100 ml. №1

Ingredients:

Each 100 ml of the solution contains 500 mg of Levofloxacin.

Dosage:

The recommended dosage is determined by the severity of the infection and the patient’s renal function. It is usually administered intravenously once daily.

Indications:

Levofloxacin-Novofarm is indicated for the treatment of various bacterial infections, including respiratory tract infections, skin and soft tissue infections, and urinary tract infections.

Contraindications:

This solution is contraindicated in patients with a history of hypersensitivity to Levofloxacin or other quinolones. It should be used with caution in patients with known or suspected CNS disorders.

Directions:

The solution should be administered slowly over 60 or 90 minutes. It is important to follow the instructions provided by a healthcare professional.

Scientific Evidence:

Levofloxacin-Novofarm has been extensively studied in clinical trials, demonstrating its efficacy in treating a wide range of bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy showed that Levofloxacin is effective against both Gram-positive and Gram-negative bacteria, making it a versatile antibiotic option.

In a comparative study published in the International Journal of Infectious Diseases, Levofloxacin was found to be as effective as other commonly used antibiotics in the treatment of respiratory infections. Its broad spectrum of activity and favorable pharmacokinetic profile make it a valuable choice in clinical practice.

Additional Information:

It is important to complete the full course of treatment with Levofloxacin-Novofarm, even if symptoms improve before the course is finished. Abrupt discontinuation of antibiotics can lead to the development of antibiotic-resistant bacteria.

Patients should be monitored for potential side effects, including tendon rupture and central nervous system effects. It is essential to weigh the benefits of treatment against the risks in each individual case.